Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A Norrby-TeglundM Kotb

Abstract

Inasmuch as normal intravenous polyspecific immunoglobulin G (IVIG) neutralizes the activity of a wide spectrum of superantigens, it may be an efficient adjunctive therapy for diseases associated with superantigen-producing organisms, including severe group A streptococcal diseases. The neutralizing activity against purified superantigens, streptococcal pyrogenic exotoxins (Spe), and a mixture of superantigens present in culture supernatant of clinical group A streptococcal isolates was determined for five IVIG preparations. A significant variation among different IVIG preparations (P < .05) and different lots of the same IVIG brand (P < .044) was found. Neutralization of SpeA activity was significantly lower than that of other streptococcal superantigens (P < .05); however, there was no correlation between SpeA binding and SpeA neutralizing activity in different IVIGs. Plasma samples obtained from patients after IVIG infusion varied in their titers of neutralizing antibodies to culture supernatants prepared from their respective isolates, and this variation paralleled differences in the neutralizing titer of the IVIG lot administered to each patient studied. The study suggests that complete neutralizing activity may be achieve...Continue Reading

Citations

Nov 30, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·F Baxter, J McChesney
Aug 14, 2012·Current Infectious Disease Reports·Susanne Toussaint, Herwig Gerlach
Nov 30, 2000·Current Infectious Disease Reports·G J Baracco, A L Bisno
Nov 30, 2000·Journal of Pharmaceutical and Biomedical Analysis·F LamariN K Karamanos
Jul 13, 2002·The Journal of Emergency Medicine·Kevin L FoxMerrill A Cohen
May 26, 1999·Infectious Disease Clinics of North America·J BannanJ B Zabriskie
Sep 25, 1999·FEMS Immunology and Medical Microbiology·A Eriksson, M Norgren
Jan 17, 2002·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·C TinguelyU E Nydegger
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Norrby-TeglundL Hammarström
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jessica DarenbergAnna Norrby-Teglund
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Birgit SchrageThomas Proft
Oct 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samir S ShahJames E Levin
Dec 13, 2007·Critical Care Medicine·K Georg KreymannStefan Kluge
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·R D LeClaire, S Bavari
Oct 12, 2000·Clinical Microbiology Reviews·M A Keller, E R Stiehm
Mar 24, 2010·Infection and Immunity·Mulualem E TilahunRichard A Goldsby
Feb 24, 2012·Journal of Clinical Microbiology·Axana HaggarAnna Norrby-Teglund
Mar 22, 2005·Paediatric Drugs·Yu-Yu ChuangTzou-Yien Lin
May 3, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan R CarapetisRoss Andrews
Jul 5, 2013·Clinical Microbiology Reviews·Adam R SpauldingPatrick M Schlievert
May 28, 2005·Expert Review of Anti-infective Therapy·Michael H YoungN Cary Engleberg
Aug 28, 2010·Critical Care Medicine·Ho H Phan, Christine S Cocanour
Oct 8, 2008·Immunological Reviews·John D Fraser, Thomas Proft
May 29, 2004·Trends in Pharmacological Sciences·Jagadeesh BayrySrini V Kaveri
Jul 26, 2015·British Medical Bulletin·Tom ParksNicola Jones
Jul 26, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Yiting ZhangWilliam C Weldon
Apr 5, 2017·Surgical Infections·Christine S CocanourMatthew R Rosengart
Jan 5, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Asher KorzetsUzi Gafter
Jan 25, 2003·Journal of Medical Microbiology·M EllisR Möllby
Nov 10, 2006·Clinical and Vaccine Immunology : CVI·Linda MaripuuMari Norgren
Jun 26, 2003·Allergy·H U Simon, P J Späth
Feb 16, 2019·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Hayk Minasyan
Sep 13, 2017·British Journal of Hospital Medicine·Oliver SandersRajnish Saha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.